Article Details

The Week In Cannabis: The New Tilray, Jazz-GW Pharma, Earnings, M&A, And More

Retrieved on: 2021-05-07 21:33:45

Tags for this article:

Click the tags to see associated articles and topics

The Week In Cannabis: The New Tilray, Jazz-GW Pharma, Earnings, M&A, And More. View article details on hiswai:

Excerpt

Following the merger, Jefferies upgraded the rating for Tilray from Underperform to Buy, while raising the price target from $4.77 to $23. Jazz ...

Article found on: www.benzinga.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up